Med-X, Inc. is in live offering mode and is actively accepting Title IV investments.
$420.00 minimum investment

Med-X, Inc.

A LEADER IN GREEN SOLUTIONS

Regulation A+
Canoga Park, CA
Pharmaceutical
Accepting International Investment

Invest in Med-X, Inc, a company that has raised over $7,000,000 from over 2,400 investors to date on StartEngine.

To create a better world for future generations we have to change. Chemicals from large conglomerates are adversely impacting the health of ourselves, our communities and the planet. As a group, we must come together and fight for a greener future. Today we ask you to join our mission to protect our families from the unnecessary dangers associated with short and long-term exposure to synthetic chemicals. Together we can bring forth a brighter and healthier future free of the toxic poisons we use in our homes and bodies every day, while simultaneously allowing our shareholders to prosper from the company’s growth and liquidity goals.


View our offering circular

A LEADER IN GREEN SOLUTIONS

The company is now raising $10M in the second round of Regulation A+ crowdfunding to support the growth of its portfolio of brands, develop new exciting products and pursue acquisition opportunities.  All of this will provide our customers with safe and effective solutions to products and services that historically overuse toxic synthetic chemicals and addictive pharmaceutical products.

THE PROBLEM

Nearly everyone on this planet is exposed to pesticides or has taken a pain relief pill. And science has proven the long-term health complications and diseases that can happen as a result.  Yet, too few people are aware that alternative, Eco-friendly products, and methods exist in the market that does the similar job, with the same efficacy, but with zero negative impact to oneself or the environment.


Reports estimate that in the United States alone over 20 billion gallons of pesticides have been sprayed on our properties and food in just the last 20 years. Globally in the same timespan, this industry has generated over $1 Trillion in revenues. So, why are we all so exposed?

Historically, the use of synthetic chemicals in all of our food, drugs, products, and industries has been controlled by a small group of very large and powerful international corporations. These corporations hold patents and spend millions of dollars lobbying governments all over the world to make sure their products are deemed safe for use, even though the long-term effects from exposure have been proven to be unhealthful and dangerous.. 


Most of these synthetic chemicals contain strong toxic/poisonous chemicals with proven long-lasting, devastating carcinogenic effects. These compounds can take generations to become nascent in the environment. As more chemicals are sprayed or used in products, the build-up just keeps compounding the pollution that harms the environment. 

146 Million Americans were Prescribed Opioids in 2017

We all know a family that has been impacted by the Opioid Public Health crisis the Pharmaceutical conglomerates have directly caused in this country by using similar unethical tactics of lobbying to get their addictive drugs in the hands of as many everyday Americans as possible. These addictive drugs that have been marketed for the use of everyday pain when science clearly proves the addictive nature of the chemicals used to make them. For a person born in 2017 the odds of dying from an Opioid Overdose is now higher than dying in a car accident.

Over 1 Billion Pounds of Pesticides are used in the United State each year

Chemicals from plastics and pesticides are now beginning to be found in our groundwater and public drinking water supplies for the first time. No wonder numerous studies are now linking diseases such as Parkinson’s disease, asthma, cancer and reproductive dysfunction to chemical pesticides.

THE MED-X SOLUTION

Med-X, Inc. has developed multiple all-natural plant-based brands of products that solve the same everyday issues people have been using chemicals to solve. Med-X is able to sell these products into the homes of everyday Americans through our partnerships with major retail and healthcare distributors as well as the leading international professional pest control distributors. The company is constantly marketing and educating the public about the dangers we face while at the same time offering real, proven effective, safe solutions. Through targeted marketing, national and international distribution venues and exposure through our media divisions, our high margin proprietary products are cutting through the noise and getting mainstream attention and sell-through. Med-X is also on the cutting edge of green product development by introducing new cannabis/hemp topical and supplement products that will also become available to consumers in the future.


We would love to tell you that our green solution products and services will bring down big chemical and big pharma., but let’s be real, that is not going to happen. The point of this mission, in fact, is more about balance, transparency, and responsibility. Our goal here is to simply offer alternatives in markets that frankly have never embraced safe and effective natural options and as you are aware, our thinking and products are beginning to resonate.

We are at the forefront of providing safer alternatives to big chemical and big pharma which will allow them to become more accountable. The consumer is demanding it. Times have changed. If you can offer a person two solutions to a problem, one is a chemical solution and one is a green solution, most Americans will now choose the green option as long as it has similar results. It is proven most Americans will actually pay substantially more for a safer option. Thankfully the products Med-X produces, fall in line with middle America value and the company has sourced product ingredients and have focused on low-cost manufacturing techniques that enable the company to offer these products at favorable costs to consumers while holding higher margins for stakeholders.


In the past, there were little or no options for a homeowner to choose an effective green pesticide to be used in their home. Likewise, there were limited safe, drug-free options for truly relieving a migraine headache or everyday chronic pain. Now there are multiple options being offered by our Med-X Divisions and more that are in final development by Med-X scientists, doctors, and formulators. These products are proven effective in clinical trials and many are already in national and international distribution channels with sell-through driving growth.

Making a Difference, One Community at a Time.

Med-X, Inc. is an innovator and leader in developing all-natural and alternative solutions to the outdated poisonous chemicals and harmful pharmaceutical products, often used in pest control and pain management. Med-X incorporates best-in-class science, research and technology for manufacturing and service capabilities across pest control, pain management, aromatherapy, by primarily utilizing essential oil product development. 


The company’s sales are represented by multiple commercial sales verticals and third-party service providers managed through various domestic and international distribution partners. Retail sales are currently conducted by over-the-counter pharmacy retailers and various e-commerce service providers. Med-X, Inc. is also focused on educating the public by supporting its digital media platforms of The Marijuana Times and The National Investor Network.

Med-X, Inc. has built a portfolio of high margin commercial and consumer product brands as well as pest control services. These proven brands help drive the company’s current revenue. This portfolio strategy gives the company flexibility and power to scale up operations, and raise revenues in any sector by acquiring other like-minded brands who fit the company mission and would like the opportunity to grow together. The company is already in talks with several small to medium-sized companies who have shown interest in being a part of a bigger green movement.


The Med-X management team is motivated to continue to grow revenue and raise the capital needed to take the company public on a national exchange. Med-X has reserved the Nasdaq ticker symbol, (MXRX) and plans to offer its investors liquidity by entering the public market in the future.

Nature-Cide

The entire Nature-Cide line of products has 10 years of research and development behind them. All of these products have been proven effective in the field by licensed pest management professionals as well as by conducting third party laboratory efficacy tests. These products are currently being utilized for major commercial and residential use worldwide in pest control, hospitality, janitorial, transportation and agriculture (Including cannabis cultivation). Nature-Cide is available to Pest Management Professionals through nationwide distribution such as Target Specialty Products, Residex, Univar, PCS and more!

Thermal-Aid

Thermal-Aid all-natural products are clinically proven and patented therapeutic heating/cooling modality designed explicitly for the medical field, to reduce swelling and relieve various pain issues. Thermal-Aid products cover a wide variety of needs for patients in all age groups for a gamut of ailments including but not limited to arthritis, fibromyalgia, multiple sclerosis, migraines, back pain, and muscle aches. Thermal-Aid products can be found in various OTC pharmacy outlets and qualify for patient insurance reimbursement and FSA programs throughout the United States.

Malibu Brands

Malibu Brands is a premium, homeopathic lifestyle brand.  Malibu Brands' first product is the Pacific Pain Relief Cream, which is a proven, natural topical analgesic cream for the temporary relief of various pains including arthritis, joint, muscle, headache, and migraine pain. Malibu Brands is working to expand its product footprint with multiple products in development including a pain cream that utilizes as an ingredient. Additionally, the Malibu Brands division is planning to embark on designing a unique clothing line that uses alternative sustainable materials such as hemp fiber and bamboo as they become readily available.

The Marijuana Times

The Marijuana Times is a thought leader in the cannabis space, especially with exposing certain blemished areas of the industry, such as the widespread unregulated chemical use by cultivators and the dangerous health impact of consuming products with high levels of synthetic chemicals. The Marijuana Times publishes content on a daily basis via its a website, IOS news application, audio podcast and daily Youtube news show. The publication is a verified Google News and Apple News, publisher.


National Investor Network

The National Investor Network is a hub for everyday investors to gather resources and information in regards to companies raising capital using public or private equity.  It serves as a portal with an extensive information base of companies and executives who are publicly raising capital or trading securities. This venue will be positioned to assist Med-X and other private and public companies with information dissemination to assist in their pursuits.

GOING FORWARD STRATEGY

Nature-Cide Products & Services

Expand market positioning with commercial advertising and expanded distribution of the Nature-Cide product lines for continued sale in Commercial Pest Control, Hospitality, Janitorial, Transportation, Housing Authorities, School Districts, Turf-Care and Agriculture including cannabis cultivation. We will also be preparing several Nature-Cide Ready to Use SKUs for consumer use to be primarily positioned in various Big Box retail.

The Nature-Cide service division plans to continue to grow it’s footprint in the Greater Los Angeles area as the management team continues to aggressively push to increase revenues and market share by acquiring existing pest control service companies and injecting the Nature-Cide products and IPM model into their existing book of business.

Thermal-Aid and Malibu Brands Products

Expand market presence of Thermal-Aid in Pain Management sectors including insurance coverage segments for Physical Therapy, Flexible Spending, and Patient Care while continuing the expansion of its retail footprint within the OTC Pharmacy space. Continue the placement of all products that fit within consumer retail with e-commerce expansion, including positioning the Malibu Brands assortment of products into the same position.

PRODUCT POSITIONING

NATIONAL PEST CONTROL AND HEALTHCARE DISTRIBUTION

Nature-Cide is being used by a growing network of commercial customers including licensed pest control companies, like the nationally positioned PestMaster Services, which provides peat control services in fourteen states. Nature-Cide currently supplies Univar Solutions, Target Specialty Products and its parent company “Rentokil Initial” in various regions including Asia and India.  The Company plans to continue aggressively marketing within the Pest Control, Hospitality, Transportation, Agriculture, and Janitorial supply markets, while also pursuing implementation of Nature-Cide in state and federal facilities throughout various regions in the United States.

PEST MANAGEMENT MARKET OVERVIEW

The global insect pest control market is projected to grow from $12.4 billion in 2016 to $17.3 billion by 2022, according to research firm MarketsandMarkets. The insect pest control market is driven by government regulations on food hygiene, public health, environmental health, and growing public awareness. The need to improve service quality for customers is expected to provide an impetus for growth in innovative pest control solutions. Lack of skilled technicians and delayed regulatory approval process for chemical products in different applications (such as residential, commercial, and industrial areas) have been considered restraining factors for the market and offer opportunities for products that fall under the less regulated FIFRA 25(b) Minimum Risk Pesticide category.

PAIN MANAGEMENT MARKET OVERVIEW

The global pain management drug market is estimated to grow from $36.6 billion in 2014 to $44.3 billion by 2020.  Pain is a distressing sensory and emotional feeling, which occurs due to tissue damage or illness. Various diseases, such as multiple sclerosis, osteoarthritis, stomach ulcer, chronic arthritis, fibromyalgia, diabetic neuropathy, and cancer can cause pain. The duration of the pain varies from short-term known as acute pain to long-term referred to as chronic pain. Traditionally, the management of pain involves the reduction or treatment of pain using a particular set of drugs. Currently, 166 people die each day from an overdose by abusing prescription opiate pain medication. The need to improve service quality and safety for patients is expected to provide an impetus for growth in the pain management solution market.

CANNABIS PRODUCTS AND SERVICES

The Med-X, management team are major proponents of the legalization of medical cannabis on a federal level. As a member of the pest control community in the cannabis industry, the team hopes to expand its footprint in this emerging market by not only supplying pest control products to cannabis and hemp cultivators but also legally participating in the cultivation and manufacturing of Hemp and Cannabis products.

Company management holds licenses for various types of applications for Pest Control and is trained and proficient in several types of cultivation, including hemp and cannabis. Management is proficient in supercritical CO2 extraction of all types of essential oils, and if and when the Federal Government eases rules and regulations on hemp and medical cannabis cultivation, sales, manufacturing and transportation, the Company is positioned to enter cultivation and manufacturing of all types of hemp and medical cannabis-related products.

CANNABIS MARKET OVERVIEW

The legalization of recreational/medical cannabis is taking over the United States. Multiple states have seen massive tax gains from legalizing recreational use while medical system states continue to be a model for other states around the country. More than half of the states in the U.S. have some medical marijuana legislation.

UNITED STATES CANNABIS LEGALIZATION

EXPECTED REVENUES ARE TOO BIG TO IGNORE

As more states legalize medical and recreational cannabis, the demand for Med-X's quality products is growing. Innovation is where Med-X excels, and Med-X consumer-ready products support the expansion of the industry.


State by state, new requirements for contaminant testing and product potency are affecting cultivators who handle pests and molds with harmful and toxic treatments of the past. As laws remove harmful and poisonous pesticides from the cultivation facilities and require nontoxic treatments, Nature-Cide is positioned to become an industry standard for organic pest control management.

WHY INVEST?

TRACTION

GROWING REVENUE

DISTRIBUTION

HEMP & CANNABIS 

MAKE A DIFFERENCE

PORTFOLIO MODEL

IN-HOUSE MEDIA

PATH TO LIQUIDITY

There is a very large demand for new effective all-natural solutions in both mainstream pest control and in the world of pharmaceuticals. The potential for the investor to prosper in these markets is there. These markets are long overdue for new ideas and innovations and opportunities to invest in these markets is rare and difficult to come by for the working-class American.


An investment in Med-X, is the opportunity to get in on the ground floor of a company that is already disrupting these markets with green options. We know that a larger portion of the market shares in these industries has to move to the safer, greener side and we are sitting perfectly to address the needs of the markets as consumers continue to demand alternative options.

COMPANY TIMELINE

FREQUENTLY ASKED QUESTIONS

All Economic Value details, including future projections, employment numbers and or statistics, are sourced from The Marijuana Business Fact Book. Produced by the Marijuana Business Daily. Industry and revenue statistics are sourced from the ArcView Market Research Report.


What is Reg A+ Equity Crowdfunding?


In June 2015, the final Regulation A+ rules under Title IV of the JOBS Act of 2012 became effective, after approval by the Securities and Exchange Commission, paving the way for companies like Med-X, Inc. to raise up to $50 million from both accredited and non-accredited investors.


Med-X, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA).


THE SECURITIES OFFERED HEREBY ARE HIGHLY SPECULATIVE. INVESTING IN SHARES OF MED-X, INC. INVOLVES SIGNIFICANT RISKS.


THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT THEIR INVESTMENT IN MED-X, INC. COULD BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET CURRENTLY EXISTS FOR THE SECURITIES AND IF A PUBLIC MARKET DEVELOPS FOLLOWING THIS OFFERING IT MAY NOT CONTINUE.


MED-X, INC. 8236 REMMET AVENUE CANOGA PARK, CA 91304 - YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

VIEW OFFERING CIRCULAR HERE


THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, MED-X, INC., ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO MED-X, INC.’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. MED-X, INC. DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

In the Press

Med-X, Inc. will not be Affected Adversely by Attorney General Jeff Sessions Rescission of the Cole Memo
January 5, 2018

According to AP reports, Attorney General Jeff Sessions has rescinding the Cole Memo, which was the Obama administration's protection of state-compliant cannabis businesses that allowed for the legal cannabis industry to flourish across the country.

Med-X, Inc. leads cannabis industry in banning pesticides for truly organic weed
March 31, 2016

Med-X, Inc. has identified the use of Nature-Cide All Purpose Insecticide, its licensed, all-natural pesticide for the advanced cultivation of cannabis. Med-X, Inc. co-founder and chief operating officer, Matthew Mills, in a Criticl article, explains the advantages of their breakthrough invention.

Med-X, Inc. Resumes Equity Crowdfunding, Allows Ordinary Americans To Invest In The Cannabis Industry
October 3, 2017

Medical cannabis-focused Med-X, Inc. has resumed its Regulation A+ (Reg A+) equity crowdfunding campaign that stems from the Jobs Act of 2012. New regulations allowing regular Americans to invest in what was once reserved for only the wealthy, is now moving to Main Street.

Inside the Cannabis Industry’s First Attempt at Equity Crowdfunding
January 15, 2016

Med-X was officially founded in 2014, but co-founders Matthew Mills and Dr. David Toomey, along with Med-X board member Dr. Allan Kurtz, had been networking together since 1999, and the idea for Med-X had begun percolating as early as 2011. Explains COO Mills, “We decided when this sector started to

Med-X Enters Into Merger & Acquisition Agreement With Pacific Shore Holdings
December 23, 2017

Med-X, Inc. (Med-X) and Pacific Shore Holdings, Inc. (PSH) announced on Friday they have entered into a definitive merger and acquisition agreement. According to the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and cultivation services arena, will combine with PSH,

Med-X, Inc. Returns to Crowdfunding Via the StartEngine Crowdfunding Portal
September 28, 2017

LOS ANGELES, Sept. 28, 2017 /PRNewswire/ -- Med-X, Inc. (Med-X) With all regulatory matters resolved in its favor, Med-X, Inc. is pleased to announce a return to Regulation A+ equity crowdfunding via the StartEngine platform.

Med-X Inc.'s Nature-Cide Insecticide Moves into Cannabis Cultivation Supply
April 4, 2016

LOS ANGELES, April 4, 2016 /PRNewswire/ -- Med-X, Inc. announced today that its Nature-Cide products are beginning to generate revenue ahead of the company's original revenue schedule due to industry demand. Med-X, Inc. has struck a deal with cultivation distribution venue GrowMinded to supply Natur

Med-X, Inc. Enters into Merger Acquisition Agreement Capturing Multiple Revenue Streams
December 22, 2017

Med-X, Inc. ("Med-X") and Pacific Shore Holdings, Inc. ("PSH") today announced that they have entered into a definitive merger and acquisition agreement ("Agreement"). Via the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and cultivation services arena, will combine

Startup Med-X, Inc.‘s specialty insecticide is paving its way to becoming a leading player in the emerging $5.4 billion cannabis industry
March 23, 2016

Med-X, an LA-based enterprise that launched in 2014, has cannabis cultivators flocking to its all-natural insecticide, Nature-Cide All Purpose, for its effectiveness in killing everything from whiteflies to spider mites.

MedX’s Matthew Mills Discusses The Booming Cannabis Industry In America with Bruce Buffer
March 11, 2016

On this week’s “IT’S TIME!” show Buffer’s guest is none other than Mills and Buffer, who is the Founder of MED-X, Inc., as well as the COO, which is a company that is taking advantage of the booming Marijuana industry in the United States at full force with products that offer effective nontoxic an

Going Green Again
August 11, 2016

Pennsylvanian Greg Pettis, a 23-year-veteran of the pest control industry, is an advocate of green pesticides. But that wasn’t always so.

Med-X, Inc. Completes Merger Acquisition Agreement Capturing Multiple Revenue Streams
April 18, 2018

Med-X, Inc. ("Med-X") and Pacific Shore Holdings, Inc. ("PSH") today announced that they have completed the merger and acquisition agreement ("Agreement") announced in December 2017. Via the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and the cultivation services

Med-X, Inc. Engages NMS Capital Advisors as Its Exclusive Investment Banking Advisor
March 26, 2018

NMS Capital Advisors, LLC ("NMS"), a leading global focused investment banking and asset management firm, announced today that it has been engaged by Med-X, Inc. ("Med-X"). NMS will be Med-X's exclusive financial advisor and investment bank, providing financial, strategic, and M&A advisory, and inve

Help your kids get through flu season with these thermal stuffed animals
January 21, 2018

These clever stuffed animals can be heated in the microwave or cooled in the freezer to make a hot compress or provide cold relief for inflammation. Each pack comes with two animals, and the options are adorable: rabbits, bears, elephants, koalas, monkeys, and hippos are all available to satisfy

Thermal-Aid Zoo Goes Viral with Reviews, Giveaways and Consumer Demand
February 8, 2013

The Thermal-Aid Zoo is a 100% natural therapeutic, cuddly heating/cooling plush animal, specifically designed for kids, to reduce swelling, ease pain and gives kids of all ages a huggable pal year round.

Residex Professional Pest Control Distribution Signs for National Placement of Nature-Cide Products
March 17, 2016

Pacific Shore Holdings, Inc. today announced that it has taken the first steps towards national pest control distribution of its Nature-Cide products by signing a Distribution Agreement with Residex, LLC. Residex who has a national footprint in the United States with 25 distribution centers in 14 st

Med-X, Inc. and Nature-Cide Sign Leading Pest Control Company Pestmaster Services to Direct Distribution Deal
September 24, 2018

"We have been focused on using safe practices since 1979," said Van Diepen. "Nature-Cide is exactly the kind of product line our customers demand that we use. We have tested these products for months and the results are there. We have a shared culture and mission to reduce risk in our communities. T

Nature-Cide Offers New Granular Product
September 25, 2018

Nature-Cide Granular is an all-natural granular insect control for turf, lawns, bedding, exterior perimeters and additional listed locations designed to kill and deter crawling insects, including emerging larvae, while repelling rodents (including voles) and reptiles.

Thermal-Aid Zoo Releases a Miniature Collectable Version of its Popular Heating and Cooling Pack for Kids
August 8, 2013

Pacific Shore Holdings, Inc. (PSHR) introduces the New Thermal-Aid Zoo Animal "Mini's". The Thermal-Aid Zoo are a 100% natural therapeutic, cuddly heating/cooling plush animal, specifically designed for kids, to reduce swelling, ease pain and gives kids of all ages a huggable pal year round. Now you

Pacific Shore Holdings launch therapeutic, plush heating/cooling toys for kids
August 9, 2013

Pacific Shore Holdings, Inc., introduced the new Thermal-Aid Zoo animal "Mini’s". The Thermal-Aid Zoo animals are a 100% natural therapeutic, heating/cooling plush animals specifically designed for kids, to reduce swelling, ease pain and give kids of all ages a "huggable" pal year round, the company

Pacific Shore Holdings, Inc. Moves Headquarters to a 20% Larger Location in Los Angeles
October 13, 2015

Pacific Shore Holdings, Inc. (PSHR) has relocated its corporate office three miles away from its former address in Chatsworth to a 20% larger building in Canoga Park, California. The new 30,000 square foot facility is located at 8236 Remmet Ave. Canoga Park, CA 91304. The move is in response to com

Nature-Cide, a Division of Pacific Shore Holdings, Inc. to Launch New Products and Labeling at National Hardware Show in Las Vegas, NV
May 5, 2014

Pacific Shore Holdings, Inc's. (OTCBB:PSHR), Nature-Cide Division, a pest management service company that's also engaged in the manufacturing of all-natural and eco-friendly pesticides, is excited to announce that they will be attending the National Hardware Convention in Las Vegas, NV, May 6 throug

Nature-Cide Granular Insecticide
August 17, 2018

Nature-Cide Granular Insecticide is labeled for tick control, as well as for several other crawling pests and emerging larvae. The water-activated formula, which has 25(b)-exempt status, can be applied in the rain. It also can be added to fertilizer for a one-pass application on golf courses, turf,

Getting in on the Ground Floor of Cannabis Investment
December 4, 2018

This brings us to Med-X, a green technology manufacturing company that has spent the past decade developing multiple successful verticals in the mainstream health and cannabis sectors, including all-natural, environmentally conscious products for pest control, aromatherapy, pain management, and cann

Med-X, Inc. Qualified by the SEC to Launch Second Crowdfunding Offering in Conjunction with Investment Banking Firm NMS Capital Advisors, LLC.
August 15, 2019

On August 12, 2019, the Securities Exchange Commission (SEC) qualified Med-X, Inc. (Med-X) to begin the company's second Regulation A+ Equity Crowdfunding Offering. This time Med-X will be working with a Broker/Dealer, NMS Capital Advisors, LLC ("NMS Capital"), in selling the offering which is now l

Updates

Follow Med-X, Inc. to get notified of future updates!